[CFA Society Boston Webinar] Genomics and Biotech Innovation in the Battle Against COVID-19
Virtual OnlyAs the world is gripped by the COVID-19 crisis, innovations in the genomics and biotech space continue to press ahead. In fact, the speed and cost of DNA sequencing has improved in such a way that scientists were able to sequence the virus behind COVID-19 in a matter of days, compared to the months it took to do the same for SARS. Furthermore, various innovative biotech companies are experimenting with unconventional treatments that could offer promise in treating and preventing the spread of this disease.